Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
Want to see IN:LALPATHLAB full AI Analyst Report?
Total Valuation
Dr. Lal PathLabs Limited has a market cap or net worth of ₹279.63B. The enterprise value is ₹273.55B.
Market Cap₹279.63B
Enterprise Value₹273.55B
Share Statistics
Dr. Lal PathLabs Limited has 167,637,770 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding167,637,770
Owned by Insiders―
Owned by Institutions0.04%
Financial Efficiency
Dr. Lal PathLabs Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 17.20%.
Return on Equity (ROE)0.20
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)17.20%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee6.74M
Profits Per Employee1.23M
Employee Count4,099
Asset Turnover0.88
Inventory Turnover36.49
Valuation Ratios
The current PE Ratio of Dr. Lal PathLabs Limited is 41.7. Dr. Lal PathLabs Limited’s PEG ratio is 12.69.
PE Ratio41.7
PS Ratio7.93
PB Ratio8.73
Price to Fair Value8.73
Price to FCF40.94
Price to Operating Cash Flow86.66
PEG Ratio12.69
Income Statement
In the last 12 months, Dr. Lal PathLabs Limited had revenue of 27.63B and earned 5.05B in profits. Earnings per share was 30.24.
Revenue27.63B
Gross Profit11.61B
Operating Income6.21B
Pretax Income6.69B
Net Income5.05B
EBITDA7.83B
Earnings Per Share (EPS)30.24
Cash Flow
In the last 12 months, operating cash flow was 3.24B and capital expenditures -1.34B, giving a free cash flow of 1.90B billion.
Operating Cash Flow3.24B
Free Cash Flow1.90B
Free Cash Flow per Share11.31
Dividends & Yields
Dr. Lal PathLabs Limited pays an annual dividend of ₹7, resulting in a dividend yield of 0.89%
Dividend Per Share₹7
Dividend Yield0.89%
Payout Ratio84.34%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change20.10%
50-Day Moving Average1.44K
200-Day Moving Average1.50K
Relative Strength Index (RSI)66.05
Average Volume (3m)3.61K
Important Dates
Dr. Lal PathLabs Limited upcoming earnings date is Jul 23, 2026, TBA (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateJul 23, 2026
Ex-Dividend Date―
Financial Position
Dr. Lal PathLabs Limited as a current ratio of 3.48, with Debt / Equity ratio of 7.93%
Current Ratio3.48
Quick Ratio3.38
Debt to Market Cap<0.01
Net Debt to EBITDA-0.91
Interest Coverage Ratio27.22
Taxes
In the past 12 months, Dr. Lal PathLabs Limited has paid 1.59B in taxes.
Income Tax1.59B
Effective Tax Rate0.24
Enterprise Valuation
Dr. Lal PathLabs Limited EV to EBITDA ratio is 27.08, with an EV/FCF ratio of 39.61.
EV to Sales7.67
EV to EBITDA27.08
EV to Free Cash Flow39.61
EV to Operating Cash Flow30.19
Balance Sheet
Dr. Lal PathLabs Limited has ₹13.02B in cash and marketable securities with ₹2.55B in debt, giving a net cash position of ₹10.47B billion.
Cash & Marketable Securities₹13.02B
Total Debt₹2.55B
Net Cash₹10.47B
Net Cash Per Share₹62.44
Tangible Book Value Per Share₹107.86
Margins
Gross margin is 53.83%, with operating margin of 22.47%, and net profit margin of 18.27%.
Gross Margin53.83%
Operating Margin22.47%
Pretax Margin24.22%
Net Profit Margin18.27%
EBITDA Margin28.32%
EBIT Margin22.47%
Analyst Forecast
The average price target for Dr. Lal PathLabs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast12.25%
EPS Growth Forecast3.57%